Can shared medical appointments in general practice support people living with chronic obstructive pulmonary disease in the North East and North Cumbria region of England?

Shared medical appointments in primary care for improving self-management of chronic obstructive pulmonary disease amongst underserved groups: a feasibility randomized control trial in North East and North Cumbria

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88389291

Enrollment

132

Registered

2023-03-03

Start date

2024-02-07

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease Respiratory Other chronic obstructive pulmonary disease

Interventions

Participants will be randomly allocated to attend a shared appointment in-person or by video link, or receive usual care. The researchers will: 1. Measure the number of patients that take part and rem

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older with a diagnosis of COPD 2. Under ongoing management in general practice 3. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Without the capacity to consent i.e., with dementia or significant learning difficulties 2. With severe mental ill-health 3. Requiring palliative care 4. Diagnosed with a condition likely to limit life expectancy to <1 year

Design outcomes

Primary

Measure	Time frame
1. Recruitment rates measured using screening logs at end of the recruitment period 2. Retention and attrition rates i.e. the proportion of participants that attend the PSMA/VSMA and the proportion of participants that return and complete questionnaires at 6 and 12 months 3. Completion rates of study questionnaires and proformas (including those to collect economic data): 3.1. Knowledge, skills and confidence to manage their own health and wellbeing measured by Patient Activation Measure at baseline, 3 months post-intervention and 9 months post-intervention 3.2. Anxiety and depression symptoms measured using Health, Anxiety and Depressions Scale at baseline, 3 months post-intervention and 9 months post-intervention 3.3. Quality of life measured using EQ-5D-5L at baseline, 3 months post-intervention and 9 months post-intervention 3.4. Healthcare service use measured by Patient care use questionnaire at baseline, 3 months post-intervention and 9 months post-intervention 3.5. Healthcare service use measured by screening logs and case report form at 12 months 3.6. Time and travel costs measured using Patient Time and Travel questionnaire at 1 month post-intervention 3.7. Primary care costs (staff time and consumables) measured using resource use proforma within 2 weeks of the intervention	—

Measure

Time frame

1. Recruitment rates measured using screening logs at end of the recruitment period 2. Retention and attrition rates i.e. the proportion of participants that attend the PSMA/VSMA and the proportion of participants that return and complete questionnaires at 6 and 12 months 3. Completion rates of study questionnaires and proformas (including those to collect economic data): 3.1. Knowledge, skills and confidence to manage their own health and wellbeing measured by Patient Activation Measure at baseline, 3 months post-intervention and 9 months post-intervention 3.2. Anxiety and depression symptoms measured using Health, Anxiety and Depressions Scale at baseline, 3 months post-intervention and 9 months post-intervention 3.3. Quality of life measured using EQ-5D-5L at baseline, 3 months post-intervention and 9 months post-intervention 3.4. Healthcare service use measured by Patient care use questionnaire at baseline, 3 months post-intervention and 9 months post-intervention 3.5. Healthcare service use measured by screening logs and case report form at 12 months 3.6. Time and travel costs measured using Patient Time and Travel questionnaire at 1 month post-intervention 3.7. Primary care costs (staff time and consumables) measured using resource use proforma within 2 weeks of the intervention

—

Secondary

Measure	Time frame
Acceptability and feasibility of SMAs and study processes: willingness to enter the trial, the acceptability of the study design, attendance at the SMAs and acceptability of the PAM questionnaire as the proposed outcome measure, collected by qualitative interviews with patient participants and interventionists within 8 weeks of the intervention	—

Countries

England, United Kingdom

Contacts

Public ContactFiona Graham

fiona.graham@newcastle.ac.uk+44 (0)7511046947

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 1, 2026